APA (7th ed.) Citation

K, P., A, F., B, S., L, B., L, P., A, K., . . . M, P. (2025). Study protocol: Fecal Microbiota Transplant combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma who failed to achieve or maintain objective response to Atezolizumab/Bevacizumab - the FAB-HCC pilot study. PloS one, 20(4), e0321189. https://doi.org/10.1371/journal.pone.0321189

Chicago Style (17th ed.) Citation

K, Pomej, et al. "Study Protocol: Fecal Microbiota Transplant Combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma Who Failed to Achieve or Maintain Objective Response to Atezolizumab/Bevacizumab - the FAB-HCC Pilot Study." PloS One 20, no. 4 (2025): e0321189. https://doi.org/10.1371/journal.pone.0321189.

MLA (9th ed.) Citation

K, Pomej, et al. "Study Protocol: Fecal Microbiota Transplant Combined with Atezolizumab/Bevacizumab in Patients with Hepatocellular Carcinoma Who Failed to Achieve or Maintain Objective Response to Atezolizumab/Bevacizumab - the FAB-HCC Pilot Study." PloS One, vol. 20, no. 4, 2025, p. e0321189, https://doi.org/10.1371/journal.pone.0321189.